Conor Tweed

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

Francesca Conradie, Tatevik R. Bagdasaryan, Pauline Howell et al. · New England Journal of Medicine · 2022 · 507 citations · Full text

Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial

Conor Tweed, Rodney Dawson, Divan A. Burger et al. · The Lancet Respiratory Medicine · 2019 · 143 citations · Full text

Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies

Annabelle South, Bec Hanley, Mitzy Gafos et al. · Trials · 2016 · 80 citations · Full text

Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study

Conor Tweed, Genevieve H. Wills, Angela M. Crook et al. · BMC Medicine · 2018 · 73 citations · Full text

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB

Conor Tweed, Genevieve H. Wills, Angela M. Crook et al. · The International Journal of Tuberculosis and Lung Disease · 2021 · 61 citations · Full text